Medical Thawing System Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Description
Medical Thawing System Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global medical thawing system market size reached US$ 191.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 301.5 Million by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028.
Medical thawing system defrosts biological samples for biology research, safe storage and transportation of biopharma products. It uses microprocessors to regulate temperature and perform cryopreserved ovum, semen, and embryo samples appropriately. At present, the increasing utilization of frozen plasma and blood products is catalyzing the demand for automated medical thawing systems worldwide. These systems assist in rapidly thawing live biological content to retain reproducibility and reduce the risk of contamination.
Medical Thawing System Market Trends:
A considerable rise in the number of individuals suffering from chronic diseases and viral and bacterial infections represents one of the major factors driving the demand for blood transfusion and medical thawing systems. This can also be accredited to the growing participation of people in blood donation campaigns across the globe. In line with this, the widespread adoption of organ transplantation and increasing organ donors are propelling the market growth. Apart from this, the increasing geriatric population that undergoes surgical procedures is contributing to the need for tissue transplantation. This, in turn, is increasing the adoption of medical thawing systems to harvest and store skins, cornea, tendons, bone joints, Dura mater, and cartilage in tissue banks. Additionally, the coronavirus disease (COVID-19) outbreak has fueled the need for tissue banks to collect tissue specimens, understand cellular responses and the biological impact of infection, and identify new therapeutic interventions and prevention strategies. Besides this, the rising adoption of regenerative medicine and personalized treatment is propelling the use of medical thawing systems in biobanking worldwide. Furthermore, increasing investments in research and development (R&D) projects to find effective solutions that treat rare diseases are anticipated to bolster the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical thawing system market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, sample type and end user.
Breakup by Product Type:
Manual
Automated
Breakup by Sample Type:
Blood
Plasma
Stem Cells
Whole Blood
Platelets
Embryo
Ovum
Semen
Breakup by End User:
Blood Banks
Hospitals
Tissue Banks
Pharmaceutical and Biotech Companies
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Barkey GmbH & Co. KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global medical thawing system market in 2022?
2. What is the expected growth rate of the global medical thawing system market during 2023-2028?
3. What are the key factors driving the global medical thawing system market?
4. What has been the impact of COVID-19 on the global medical thawing system market?
5. What is the breakup of the global medical thawing system market based on the product type?
6. What is the breakup of the global medical thawing system market based on the sample type?
7. What is the breakup of the global medical thawing system market based on the end user?
8. What are the key regions in the global medical thawing system market?
9. Who are the key players/companies in the global medical thawing system market?
The global medical thawing system market size reached US$ 191.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 301.5 Million by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028.
Medical thawing system defrosts biological samples for biology research, safe storage and transportation of biopharma products. It uses microprocessors to regulate temperature and perform cryopreserved ovum, semen, and embryo samples appropriately. At present, the increasing utilization of frozen plasma and blood products is catalyzing the demand for automated medical thawing systems worldwide. These systems assist in rapidly thawing live biological content to retain reproducibility and reduce the risk of contamination.
Medical Thawing System Market Trends:
A considerable rise in the number of individuals suffering from chronic diseases and viral and bacterial infections represents one of the major factors driving the demand for blood transfusion and medical thawing systems. This can also be accredited to the growing participation of people in blood donation campaigns across the globe. In line with this, the widespread adoption of organ transplantation and increasing organ donors are propelling the market growth. Apart from this, the increasing geriatric population that undergoes surgical procedures is contributing to the need for tissue transplantation. This, in turn, is increasing the adoption of medical thawing systems to harvest and store skins, cornea, tendons, bone joints, Dura mater, and cartilage in tissue banks. Additionally, the coronavirus disease (COVID-19) outbreak has fueled the need for tissue banks to collect tissue specimens, understand cellular responses and the biological impact of infection, and identify new therapeutic interventions and prevention strategies. Besides this, the rising adoption of regenerative medicine and personalized treatment is propelling the use of medical thawing systems in biobanking worldwide. Furthermore, increasing investments in research and development (R&D) projects to find effective solutions that treat rare diseases are anticipated to bolster the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical thawing system market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, sample type and end user.
Breakup by Product Type:
Manual
Automated
Breakup by Sample Type:
Blood
Plasma
Stem Cells
Whole Blood
Platelets
Embryo
Ovum
Semen
Breakup by End User:
Blood Banks
Hospitals
Tissue Banks
Pharmaceutical and Biotech Companies
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Barkey GmbH & Co. KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global medical thawing system market in 2022?
2. What is the expected growth rate of the global medical thawing system market during 2023-2028?
3. What are the key factors driving the global medical thawing system market?
4. What has been the impact of COVID-19 on the global medical thawing system market?
5. What is the breakup of the global medical thawing system market based on the product type?
6. What is the breakup of the global medical thawing system market based on the sample type?
7. What is the breakup of the global medical thawing system market based on the end user?
8. What are the key regions in the global medical thawing system market?
9. Who are the key players/companies in the global medical thawing system market?
Table of Contents
143 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global Medical Thawing System Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
- 6 Market Breakup by Product Type
- 6.1 Manual
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Automated
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 7 Market Breakup by Sample Type
- 7.1 Blood
- 7.1.1 Market Trends
- 7.1.2 Key Segments
- 7.1.2.1 Plasma
- 7.1.2.2 Stem Cells
- 7.1.2.3 Whole Blood
- 7.1.2.4 Platelets
- 7.1.3 Market Forecast
- 7.2 Embryo
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Ovum
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Semen
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 8 Market Breakup by End User
- 8.1 Blood Banks
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Hospitals
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Tissue Banks
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Pharmaceutical and Biotech Companies
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
- 10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
- 11 Value Chain Analysis
- 12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
- 13 Price Analysis
- 14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Barkey GmbH & Co. KG
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Biolife Solutions Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.3 Boekel Scientific
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Cardinal Health Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 General Electric Company
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Helmer Scientific Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Hospicare Systems
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 labcold Limited
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 MMS Medical and Laboratory Supplies
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Sarstedt AG & Co. KG
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Sartorius AG
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Terumo Penpol Private Limited (Terumo Corporation)
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.13 Thermo Fisher Scientific Inc.
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.13.4 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
